Results 101 to 110 of about 3,371 (214)

CLINICAL POTENTIAL OF CARIPRAZINE IN THE TREATMENT OF ACUTE MANIA [PDF]

open access: yes, 2013
Cariprazine (RGH-188, trans-4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexyl-amine hydrochloride), is a novel antipsychotic with dopamine D2 and D3 receptors antagonist–partial agonist properties. Cariprazine has also
Esat Timuçin Oral   +2 more
core   +1 more source

Stability indicating RP-HPLC method for estimation of cariprazine hydrochloride in human plasma

open access: yesJournal of Applied Pharmaceutical Research
Objective: The objective of the study is to create and validate the easy, dependable, accurate, sensitive, and selective RP-HPLC method for estimating Cariprazine HCl in human plasma.
Mohini Shelke   +4 more
doaj   +1 more source

Exploring cariprazine as a treatment option for varied depression symptom clusters

open access: yesFrontiers in Psychiatry
Major depressive disorder (MDD) is among the most prevalent psychiatric conditions and a leading cause of disability worldwide. MDD presents a diverse range of symptoms that significantly impact personal, societal, and economic dimensions.
Bojana Pejušković   +5 more
doaj   +1 more source

Cariprazine-Induced Extrapyramidal Symptoms and a Rare Downward Eye Deviation in Oculogyric Crisis: A Case Series

open access: yesIndian Journal of Psychological Medicine
Cariprazine is one of the newer generation antipsychotics with dopamine receptor partial agonist activity which has been approved for management of schizophrenia and bipolar affective disorder.
Devendra Singh Basera   +3 more
doaj   +1 more source

Cariprazine: An Antipsychotic Medication with High Therapeutic Potential [PDF]

open access: yes
Introduction and purposeCariprazine is an atypical antipsychotic drug approved for the treatment of schizophrenia, as well as manic and mixed episodes associated with bipolar disorder.
Babkiewicz-Jahn, Kamila   +9 more
core   +1 more source

Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis [PDF]

open access: yes
\ua9 2024 The AuthorsBackground: Cariprazine has emerged as a promising augmenting treatment agent for unipolar depression and as a monotherapy option for bipolar depression.
Fernandes LA   +7 more
core  

Effects of cariprazine on cholesterol, glucose, and weight in patients with schizophrenia: a systematic review and meta-analysis. [PDF]

open access: yesTher Adv Psychopharmacol
Berardelli I   +6 more
europepmc   +1 more source

High-density EEG study in patients with schizophrenia treated with cariprazine. [PDF]

open access: yesInt J Neuropsychopharmacol
Czobor P   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy